{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:13:36Z","timestamp":1758046416804,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.pharma.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T09:50:29Z","timestamp":1452678629000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["D\u00e9veloppement et validation d\u2019une m\u00e9thode de dosage des traces de d\u00e9tergents inactivants totaux du prion"],"prefix":"10.1016","volume":"74","author":[{"given":"T.","family":"Briot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Robelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Riou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-V.","family":"Lebelle-Dehaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2011","series-title":"Instruction DGS\/R13\u00a0no 2011-449","author":"Minist\u00e8re fran\u00e7ais de la sant\u00e9","key":"10.1016\/j.pharma.2015.12.003_bib0110"},{"year":"2011","series-title":"Protocole standard prion","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9","key":"10.1016\/j.pharma.2015.12.003_bib0115"},{"year":"2014","series-title":"Liste des produits inactivants totaux au regard du PSP (novembre 2011), utilisables dans le cadre des proc\u00e9dures pr\u00e9vues par l\u2019instruction DGS\/RI3\/2011\/449\u00a0du 1er d\u00e9cembre 2011","author":"Agence national de s\u00e9curit\u00e9 du m\u00e9dicament","key":"10.1016\/j.pharma.2015.12.003_bib0120"},{"key":"10.1016\/j.pharma.2015.12.003_bib0125","series-title":"Fiche de donn\u00e9es de s\u00e9curit\u00e9 conforme \u00e0 r\u00e8glement (CE) no 1907\/2006\u00a0: neodisher SeptoClean","first-page":"1","author":"Dr Weigert","year":"2014"},{"year":"2015","series-title":"Actanios LDI\u00a0: dossier technique","author":"Anios laboratories","key":"10.1016\/j.pharma.2015.12.003_bib0130"},{"key":"10.1016\/j.pharma.2015.12.003_bib0135","series-title":"Fiche signal\u00e9tique, Hamo 100(r) Prion Inactivating Detergent","first-page":"1","author":"Steris Corporation","year":"2011"},{"year":"2013","series-title":"Spetoclean\u00a0: dossier technique","author":"Weigert","key":"10.1016\/j.pharma.2015.12.003_bib0140"},{"year":"2010","series-title":"ISO 15993-1\u00a0: \u00e9valuation biologique des dispositifs m\u00e9dicaux - partie 1\u00a0: \u00e9valuation et essais au sein d\u2019un processus de gestion du risque","author":"Agence fran\u00e7aise de normalisation","key":"10.1016\/j.pharma.2015.12.003_bib0145"},{"year":"2012","series-title":"Arbeitskreis Instrumentenaufbereitung. Traiter les instruments de fa\u00e7on en pr\u00e9servant leur valeur","key":"10.1016\/j.pharma.2015.12.003_bib0150"},{"year":"2009","series-title":"ISO 15883-1\u00a0: laveurs d\u00e9sinfecteurs - partie 1\u00a0: exigences g\u00e9n\u00e9rales, termes et d\u00e9finitions et essais","author":"Agence fran\u00e7aise de normalisation","key":"10.1016\/j.pharma.2015.12.003_bib0155"},{"issue":"1","key":"10.1016\/j.pharma.2015.12.003_bib0160","first-page":"2","volume":"16","author":"Carter","year":"2008","journal-title":"Zentral st\u00e9rilisation"},{"journal-title":"Journal officiel des Communaut\u00e9s europ\u00e9ennes","article-title":"Directives 93\/42\/CEE relative aux dispositifs m\u00e9dicaux (L 169\/2)","year":"1993","key":"10.1016\/j.pharma.2015.12.003_bib0165"},{"year":"2012","series-title":"Fiche toxicologie (FT35)\u00a0: hydroxyde de potassium et solutions aqueuses","author":"Institut national de recherche et de s\u00e9curit\u00e9","key":"10.1016\/j.pharma.2015.12.003_bib0170"},{"year":"2006","series-title":"Fiche toxicologie (FT259)\u00a0: m\u00e9tasilicate de disodium","author":"Institut national de recherche et de s\u00e9curit\u00e9","key":"10.1016\/j.pharma.2015.12.003_bib0175"},{"year":"2009","series-title":"ISO 15993-1\u00a0: \u00e9valuation biologique des dispositifs m\u00e9dicaux\u00a0\u2013\u00a0partie 1\u00a0: \u00e9valuation et essais au sein d\u2019un processus de gestion du risque","author":"Agence fran\u00e7aise de normalisation","key":"10.1016\/j.pharma.2015.12.003_bib0180"},{"year":"2012","series-title":"LDI cytotoxicity test by direct contact. Report No.: 151572","author":"Biomatech","key":"10.1016\/j.pharma.2015.12.003_bib0185"},{"key":"10.1016\/j.pharma.2015.12.003_bib0190","series-title":"Journ\u00e9es internationales francophones de st\u00e9rilisation","article-title":"Cin\u00e9tique de rin\u00e7age et recherche de traces des ingr\u00e9dients des d\u00e9tergents pour LDI\u00a0: validation du choix des traceurs et optimisation des temps de cycles (communication orale)","author":"Rauwel","year":"2012"},{"year":"2015","series-title":"SH GTA 04\u00a0: guide de v\u00e9rification\/validation des m\u00e9thodes en biologie m\u00e9dicale","author":"COFRAC","key":"10.1016\/j.pharma.2015.12.003_bib0195"},{"article-title":"Q 2 (R1): validation of analytical procedures: text and methodology","year":"2005","series-title":"International Conference on Harmonisation","key":"10.1016\/j.pharma.2015.12.003_bib0200"},{"issue":"11","key":"10.1016\/j.pharma.2015.12.003_bib0205","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1515\/cclm.1983.21.11.709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I","volume":"21","author":"Passing","year":"1983","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2015.12.003_bib0105","series-title":"MethComp: functions for analysis of agreement in method comparison studies. R package version","first-page":"1","author":"Carstensen","year":"2013"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450915001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450915001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:32:43Z","timestamp":1757719963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450915001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0003450915001650"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2015.12.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9veloppement et validation d\u2019une m\u00e9thode de dosage des traces de d\u00e9tergents inactivants totaux du prion","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS on behalf of Acad\u00e9mie Nationale de Pharmacie.","name":"copyright","label":"Copyright"}]}}